Evidence map›Paper›PMID 23300442›Full record

ArticlePLoS pathogens2012

Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G.

David J Stanley, Koen Bartholomeeusen, David C Crosby, Dong Young Kim, Eunju Kwon, Linda Yen, Nathalie Caretta Cartozo, Ming Li, Stefanie Jäger, Jeremy Mason-Herr and 6 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Association Between Neddylation and Immune Response.Frontiers in cell and developmental biology · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Characterization of an A3G-VifMolecular & cellular proteomics : MCP · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Roles of neddylation against viral infections.Cellular & molecular immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

David J StanleyDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America.
Koen Bartholomeeusen
David C Crosby
Dong Young Kim
Eunju Kwon
Linda Yen
Nathalie Caretta Cartozo
Ming Li
Stefanie Jäger
Jeremy Mason-Herr
Fumiaki Hayashi
Shigeyuki Yokoyama
Nevan J Krogan
Reuben S Harris
Boris Matija Peterlin
John D Gross
University of California, San Francisco · USQB3 · USSystems Biology Institute · JPUniversity of Minnesota · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FRANKEL, ALAN D · 2007 to 2018
$48.8M
YEAST THREONINE &SERINE KINASESP41RR001614 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ORTIZ DE MONTELLANO, PAUL R · 1985 to 2011
$24.1M
Molecular Virology and Systems Biology Screening CoreP01AI090935 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI YOUNG, JOHN A T · 2010 to 2014
$20.4M
Rewiring Therapeutic Cells: User-Controlled T Cells and Stem CellsP50GM081879 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIM, WENDELL A · 2010 to 2017
$19.0M
NCRR NIH HHS P41 RR001614NIAID NIH HHS P01 AI090935NIAID NIH HHS P30 AI027763NIGMS NIH HHS P50 GM081879NIGMS NIH HHS P50 GM082250
6 · The paper itself

Abstract

Cellular restriction factors help to defend humans against human immunodeficiency virus (HIV). HIV accessory proteins hijack at least three different Cullin-RING ubiquitin ligases, which must be activated by the small ubiquitin-like protein NEDD8, in order to counteract host cellular restriction factors. We found that conjugation of NEDD8 to Cullin-5 by the NEDD8-conjugating enzyme UBE2F is required for HIV Vif-mediated degradation of the host restriction factor APOBEC3G (A3G). Pharmacological inhibition of the NEDD8 E1 by MLN4924 or knockdown of either UBE2F or its RING-protein binding partner RBX2 bypasses the effect of Vif, restoring the restriction of HIV by A3G. NMR mapping and mutational analyses define specificity determinants of the UBE2F NEDD8 cascade. These studies demonstrate that disrupting host NEDD8 cascades presents a novel antiretroviral therapeutic approach enhancing the ability of the immune system to combat HIV.

Indexed as

APOBEC-3G DeaminaseCarrier ProteinsCD4-Positive T-LymphocytesCell LineCullin ProteinsCyclopentanesCytidine DeaminaseHEK293 CellsHIVHIV InfectionsHumansMagnetic Resonance ImagingNEDD8 ProteinPyrimidinesRNA InterferenceRNA, Small InterferingAPOBEC-3G DeaminaseAPOBEC3G protein, humanCarrier ProteinsCUL5 protein, humanCullin ProteinsCyclopentanesCytidine DeaminaseNEDD8 ProteinNEDD8 protein, humanpevonedistatPyrimidinesRBX1 protein, humanRNA, Small InterferingRNF7 protein, humanUbiquitin-Protein LigasesUbiquitinsvif Gene Products, Human Immunodeficiency Virus

Identifiers

PMID23300442
PMCPMC3531493
OpenAlexW2018507236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.